Codes / ICD10CM / M10.229

M10.229 Drug-induced gout, unspecified elbow

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Drug-induced gout, unspecified elbow
  • Technical Term: Drug-induced arthropathy affecting the elbow

Summary

Drug-induced gout is a form of inflammatory arthritis caused by medications that elevate uric acid levels, leading to urate crystal deposition in joints. This results in acute inflammation and pain, specifically affecting the elbow joint in this case.

Causes

This condition arises from medications that increase uric acid production or reduce its excretion. Common triggers include diuretics, immunosuppressants, low-dose aspirin, and certain chemotherapy agents. The elevated uric acid promotes crystal formation in synovial fluid, triggering an inflammatory response in the elbow joint.

Risk Factors

  • Use of medications known to raise uric acid levels
  • Pre-existing hyperuricemia or gout history
  • Renal impairment (reduced uric acid excretion)
  • Dehydration or high-purine diets (exacerbating uric acid buildup)

Symptoms

  • Sudden, severe elbow pain (often nocturnal)
  • Swelling, redness, and warmth in the elbow joint
  • Limited range of motion in the elbow
  • Tenderness to touch
  • Fever (in severe cases)

Diagnosis

Diagnosis involves a physical exam of the inflamed elbow joint, blood tests for uric acid levels, and joint fluid analysis to detect urate crystals. Imaging (e.g., X-rays, ultrasound) may assess joint damage, while medication history confirms the drug-induced etiology.

Treatment Options

Treatment focuses on managing acute symptoms and addressing the underlying cause. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may reduce inflammation and pain. Stopping the offending medication, if possible, is critical. Long-term management may include uric acid-lowering therapies if hyperuricemia persists.

Prognosis and Follow-Up

Prognosis depends on early intervention and discontinuation of the causative drug. Acute episodes typically resolve with treatment, but recurrent inflammation may occur if the trigger persists. Regular follow-up monitors uric acid levels and joint function to prevent chronic damage.

Complications

Untreated or recurrent episodes can lead to chronic joint damage, tophi (urate crystal deposits), or persistent pain. Severe inflammation may cause limited mobility or secondary infections.

Lifestyle & Prevention

Avoiding known uric acid-raising medications (when feasible) and maintaining hydration can reduce risk. A low-purine diet and weight management may also help manage uric acid levels.

When to Seek Professional Help

Seek care if elbow pain is severe, sudden, or accompanied by swelling, redness, or fever. Prompt evaluation is needed to confirm diagnosis and initiate treatment, especially if symptoms worsen or persist.

Tips for Medical Coders

Use M10.229 for drug-induced gout affecting the elbow when the specific side (right/left) is not documented. Ensure the medical record supports the drug-induced etiology and elbow involvement. Documentation should clarify the absence of bilateral or side-specific details to justify the "unspecified" designation.

Book a walkthrough

M10.229 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.